SAFIRA BLOG
Key Components of a Comprehensive eCOA Library
In the rapidly evolving landscape of clinical research, the integration of technology is not just a trend but a necessity. Electronic Clinical Outcome Assessments (eCOA) are at the forefront of this transformation, significantly enhancing the efficiency, consistency,...
Social Intelligence Report: Patients & Clinical Trials in the U.S.
Safira’s Center for Social & Digital Excellence recently completed a social intelligence report looking at the trends in social conversations from patients and caregivers regarding their feelings and drivers related to clinical trials. Among the top insights...
Navigating Clinical Trials: The Crucial Role of RTSM in Enhancing Efficiency and Integrity
In the complex world of clinical trials, Randomization and Trial Supply Management (RTSM) plays a pivotal role. This technology is not just a tool but a critical element that enhances the efficiency and integrity of clinical trials. Here's a closer look at the...
Electronic Patient-Reported Outcome Measures Japanese Translation Released
Bill Byrom and Willie Muehlhausen’s groundbreaking book Electronic Patient-Reported Outcome Measures has been released in a Japanese translated version. Like the popular first edition published in 2018, this book concisely covers the entire landscape of...
Unlocking Insights on FDA Expectations: On-Demand Webinar Recap
In the rapidly evolving landscape of clinical research, understanding the nuances of regulatory expectations is crucial. This is particularly true when it comes to patient-reported outcomes (PROs), which are increasingly vital in shaping drug development strategies...
Five phone calls…
Many of my friends in the industry know that I have strong feelings about not including eCOA screenshots in IRB/EC/Regulatory submissions. Our industry colleagues Stephen Raymond(RIP), Bill Barrasso, Art Gertel and A Hackett started the process in...
Tuberculosis: Patient Sentiment
We recently conducted a comprehensive, multilingual analysis of social media conversations regarding tuberculosis, focusing on insights from Japan, the Philippines, India, and Peru. Initially, we sifted through over 3 million posts from 1 million authors, but after...
User Acceptance Testing
Let us start with the conclusion: The Sponsor is ultimately responsible for User Acceptance Testing (UAT) of the final system and should do conduct an independent UAT. There seems to be some confusion about what UAT is in the context of the configuration of an eCOA...
Rethinking Today’s ePRO Delivery for Tomorrow’s Clinical Trials
The clinical trial landscape is evolving, but is eCOA/ePRO keeping pace? Recently Safira founder Willie Muehlhausen sat down with VP of Strategy, MyVeeva for Patients, Tim Davis, discuss how ePRO delivery should change to better serve modern trials.
The Benefits of eCOA in Clinical Trials
The benefits of eCOA in clinical trials: Improving Data Collection and Patient Experience are discussed. eCOA platforms provide electronic forms that participants can complete directly using familiar devices such as smartphones, tablets, or computers. This not only...
Using Large Language Models & Other Machine Learning Methods in Clinical Trials
Safira's Senior Director of Social Media & Digital Excellence, Michael Durwin, is slated to deliver a keynote address at the upcoming eClinical Forum Autumn Workshop, scheduled for October 24-26 at the Janssen Research and Development headquarters in Spring House,...
PharmaVoice 100 Winner:
Gauri Nagrani Cloughjordan, Co. Tipperary, Ireland SEPTEMBER 19, 2023 – Safira Partners co-founder Gauri Nagrani has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry. Nagrani brings...
Gauri Nagrani has been honored as a PharmaVoice 100 winner
Cloughjordan, Co. Tipperary, Ireland SEPTEMBER 19, 2023 – Safira Partners co-founder Gauri Nagrani has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry. Nagrani brings more than 15+...
Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device: Results of a Randomized Equivalence Trial
Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device: Results of a Randomized Equivalence Trial Bill Byrom, PhD, Helen Doll, DPhil, Willie...
Measurement Equivalence of Patient-Reported Outcome Measures Migrated to Electronic Formats: A Review of Evidence and Recommendations for Clinical Trials and Bring Your Own Device
Introduction: Patient-Reported Outcome (PRO) data collection has taken a digital leap forward, becoming a pivotal part of contemporary clinical trials and patient care. As technology advances, more clinical studies are leaning towards electronic platforms like...
Maximizing the value of wearables by the remote collection and analysis of raw 100 Hz data
Unlocking Potential: Remote Data Transmission and Machine Learning in Motor Movement Analysis The digital age has spurred innovation in many sectors, including clinical research. This study steps into the promising intersection of wearables, remote data transmission,...
Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on Qualitative Synthesis of Validation Studies
Exploring the Transition Migrating Patient-Reported Outcomes from Paper to Electronic The digitization wave presents the opportunity to migrate patient-reported outcome (PRO) instruments from paper to electronic platforms. This research delves into the intricacies of...
Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically: Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies
From Paper to Digital: Best Practices in Migrating Patient-Reported Outcomes With the digital transformation wave, there's a vital need to transition patient-reported outcome (PRO) instruments from traditional paper forms to electronic formats (ePRO). This...
Approach to Using Machine Learning Algorithms for Fraud Detection in Real World Data from Wrist Worn Wearable Devices
Machine Learning in Wearable Device Fraud Detection With wearable devices playing a pivotal role in modern healthcare and clinical trials, ensuring the accuracy and authenticity of the data they produce is paramount. This research delves into the application of...
Utilizing Machine Learning And ECG Data for Continuous User Authentication of Patients During a Clinical Trial
Machine Learning for Continuous User Authentication via ECG Data in Clinical Trials Harnessing the power of wearable devices for data capture during clinical trials and healthcare applications is becoming a mainstay. However, the looming threat of fraudulent behavior...
Using Machine Learning for Signal Detection in Realworld Data from Wristworn Wearable Devices to Identify Fraudulent Behaviour
With the surge in wearable device data in clinical trials, ensuring the authenticity and attribution of this data to the correct individual has become paramount. This research sheds light on the application of Machine Learning to detect fraudulent data generation from...
Optimised Convolutional Neural Networks for Heart Rate Estimation and Human Activity Recognition in Wrist Worn Sensing Applications
Optimized Deep Learning for Wearable Heart Rate Monitors Wrist-worn smart devices have revolutionized health monitoring. But with challenges like battery life, motion-induced errors, and the need for cost-effective technology, how can we ensure consistent, accurate...
Equivalence of Electronic vs. Paper Administration of Patient Outcome Measures
In an extensive review and meta-analysis following up on Gwaltney et al’s 2008 research, this paper examined the comparability between electronic and traditional paper methods of administering patient reported outcome measures (PROMs). Drawing from data between 2007...
Outsourcing in Clinical Trials Conference
Join us for “Quality eCOA: On Time and Within Budget. How Partnering with Specialists Achieves This for Any Sponsor Project” Talk at the 2023 Outsourcing in Clinical Trials Conference – UK Join us at the 2023 Outsourcing in Clinical Trials – UK and Ireland Conference....
Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry
The purpose of this guidance is to provide recommendations to sponsors developing medical products on the approach for developing a Race and Ethnicity Diversity Plan (referred to as the “Plan”) to enroll adequate numbers of participants in clinical trials from...
Screenshot reports for IRB/EC submissions
Screen Reports have been bugging us for years. Allegedly all patient-facing materials need to be approved by the IRB/EC prior to the start of participant enrolment. Producing these screen reports for the submission to regulators and to IRB/ECs is often requested prior...
The Role of eCOA in Decentralized Clinical Trials
Decentralized clinical trials (DCTs) are revolutionizing the way we conduct medical research. By eliminating the need for physical visits to clinical sites, DCTs make it easier for patients to participate, potentially leading to more diverse and representative trial...
Enhancing Real World Evidence with Social Intelligence: Unveiling the Full Patient Story
In the realm of healthcare, the pursuit of effective treatments and patient outcomes is a continuous journey. One invaluable tool that has gained significant traction in recent years is Real World Evidence (RWE), a collection of patient-related data aimed at shaping...
Digital Quality in Clinical Trials
Date: November 28 & 29, 2023 Location: Amsterdam, NL Willie Muehlhausen, founder of Safira Clinical Research and Mark Poulton, Executive Director of Poulton Quality Solutions and former GCP Inspector at MHRA, will be presenting on improving the digital quality of...
PharmaVoice 100 Winner:
Gauri Nagrani Cloughjordan, Co. Tipperary, Ireland SEPTEMBER 19, 2023 – Safira Partners co-founder Gauri Nagrani has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry. Nagrani brings...
Gauri Nagrani has been honored as a PharmaVoice 100 winner
Cloughjordan, Co. Tipperary, Ireland SEPTEMBER 19, 2023 – Safira Partners co-founder Gauri Nagrani has been honored as a PharmaVoice 100 winner. This annual list recognizes the most inspiring people in the life sciences industry. Nagrani brings more than 15+...
Unlocking Insights on FDA Expectations: On-Demand Webinar Recap
In the rapidly evolving landscape of clinical research, understanding the nuances of regulatory expectations is crucial. This is particularly true when it comes to patient-reported outcomes (PROs), which are increasingly vital in shaping drug development strategies...
Using Large Language Models & Other Machine Learning Methods in Clinical Trials
Safira's Senior Director of Social Media & Digital Excellence, Michael Durwin, is slated to deliver a keynote address at the upcoming eClinical Forum Autumn Workshop, scheduled for October 24-26 at the Janssen Research and Development headquarters in Spring House,...
Outsourcing in Clinical Trials Conference
Join us for “Quality eCOA: On Time and Within Budget. How Partnering with Specialists Achieves This for Any Sponsor Project” Talk at the 2023 Outsourcing in Clinical Trials Conference – UK Join us at the 2023 Outsourcing in Clinical Trials – UK and Ireland Conference....
Digital Quality in Clinical Trials
Date: November 28 & 29, 2023 Location: Amsterdam, NL Willie Muehlhausen, founder of Safira Clinical Research and Mark Poulton, Executive Director of Poulton Quality Solutions and former GCP Inspector at MHRA, will be presenting on improving the digital quality of...
Unlocking Insights on FDA Expectations: On-Demand Webinar Recap
In the rapidly evolving landscape of clinical research, understanding the nuances of regulatory expectations is crucial. This is particularly true when it comes to patient-reported outcomes (PROs), which are increasingly vital in shaping drug development strategies...
Rethinking Today’s ePRO Delivery for Tomorrow’s Clinical Trials
The clinical trial landscape is evolving, but is eCOA/ePRO keeping pace? Recently Safira founder Willie Muehlhausen sat down with VP of Strategy, MyVeeva for Patients, Tim Davis, discuss how ePRO delivery should change to better serve modern trials.
Diversity Plans to Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry
The purpose of this guidance is to provide recommendations to sponsors developing medical products on the approach for developing a Race and Ethnicity Diversity Plan (referred to as the “Plan”) to enroll adequate numbers of participants in clinical trials from...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Key Components of a Comprehensive eCOA Library
In the rapidly evolving landscape of clinical research, the integration of technology is not just a trend but a necessity. Electronic Clinical Outcome Assessments (eCOA) are at the forefront of this transformation, significantly enhancing the efficiency, consistency,...
Electronic Patient-Reported Outcome Measures Japanese Translation Released
Bill Byrom and Willie Muehlhausen’s groundbreaking book Electronic Patient-Reported Outcome Measures has been released in a Japanese translated version. Like the popular first edition published in 2018, this book concisely covers the entire landscape of...
Five phone calls…
Many of my friends in the industry know that I have strong feelings about not including eCOA screenshots in IRB/EC/Regulatory submissions. Our industry colleagues Stephen Raymond(RIP), Bill Barrasso, Art Gertel and A Hackett started the process in...
Rethinking Today’s ePRO Delivery for Tomorrow’s Clinical Trials
The clinical trial landscape is evolving, but is eCOA/ePRO keeping pace? Recently Safira founder Willie Muehlhausen sat down with VP of Strategy, MyVeeva for Patients, Tim Davis, discuss how ePRO delivery should change to better serve modern trials.
The Benefits of eCOA in Clinical Trials
The benefits of eCOA in clinical trials: Improving Data Collection and Patient Experience are discussed. eCOA platforms provide electronic forms that participants can complete directly using familiar devices such as smartphones, tablets, or computers. This not only...
Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on Qualitative Synthesis of Validation Studies
Exploring the Transition Migrating Patient-Reported Outcomes from Paper to Electronic The digitization wave presents the opportunity to migrate patient-reported outcome (PRO) instruments from paper to electronic platforms. This research delves into the intricacies of...
Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically: Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies
From Paper to Digital: Best Practices in Migrating Patient-Reported Outcomes With the digital transformation wave, there's a vital need to transition patient-reported outcome (PRO) instruments from traditional paper forms to electronic formats (ePRO). This...
Equivalence of Electronic vs. Paper Administration of Patient Outcome Measures
In an extensive review and meta-analysis following up on Gwaltney et al’s 2008 research, this paper examined the comparability between electronic and traditional paper methods of administering patient reported outcome measures (PROMs). Drawing from data between 2007...
Screenshot reports for IRB/EC submissions
Screen Reports have been bugging us for years. Allegedly all patient-facing materials need to be approved by the IRB/EC prior to the start of participant enrolment. Producing these screen reports for the submission to regulators and to IRB/ECs is often requested prior...
The Role of eCOA in Decentralized Clinical Trials
Decentralized clinical trials (DCTs) are revolutionizing the way we conduct medical research. By eliminating the need for physical visits to clinical sites, DCTs make it easier for patients to participate, potentially leading to more diverse and representative trial...
Key Components of a Comprehensive eCOA Library
In the rapidly evolving landscape of clinical research, the integration of technology is not just a trend but a necessity. Electronic Clinical Outcome Assessments (eCOA) are at the forefront of this transformation, significantly enhancing the efficiency, consistency,...
Social Intelligence Report: Patients & Clinical Trials in the U.S.
Safira’s Center for Social & Digital Excellence recently completed a social intelligence report looking at the trends in social conversations from patients and caregivers regarding their feelings and drivers related to clinical trials. Among the top insights...
Navigating Clinical Trials: The Crucial Role of RTSM in Enhancing Efficiency and Integrity
In the complex world of clinical trials, Randomization and Trial Supply Management (RTSM) plays a pivotal role. This technology is not just a tool but a critical element that enhances the efficiency and integrity of clinical trials. Here's a closer look at the...
Electronic Patient-Reported Outcome Measures Japanese Translation Released
Bill Byrom and Willie Muehlhausen’s groundbreaking book Electronic Patient-Reported Outcome Measures has been released in a Japanese translated version. Like the popular first edition published in 2018, this book concisely covers the entire landscape of...
Unlocking Insights on FDA Expectations: On-Demand Webinar Recap
In the rapidly evolving landscape of clinical research, understanding the nuances of regulatory expectations is crucial. This is particularly true when it comes to patient-reported outcomes (PROs), which are increasingly vital in shaping drug development strategies...
Five phone calls…
Many of my friends in the industry know that I have strong feelings about not including eCOA screenshots in IRB/EC/Regulatory submissions. Our industry colleagues Stephen Raymond(RIP), Bill Barrasso, Art Gertel and A Hackett started the process in...
Tuberculosis: Patient Sentiment
We recently conducted a comprehensive, multilingual analysis of social media conversations regarding tuberculosis, focusing on insights from Japan, the Philippines, India, and Peru. Initially, we sifted through over 3 million posts from 1 million authors, but after...
User Acceptance Testing
Let us start with the conclusion: The Sponsor is ultimately responsible for User Acceptance Testing (UAT) of the final system and should do conduct an independent UAT. There seems to be some confusion about what UAT is in the context of the configuration of an eCOA...
Rethinking Today’s ePRO Delivery for Tomorrow’s Clinical Trials
The clinical trial landscape is evolving, but is eCOA/ePRO keeping pace? Recently Safira founder Willie Muehlhausen sat down with VP of Strategy, MyVeeva for Patients, Tim Davis, discuss how ePRO delivery should change to better serve modern trials.
The Benefits of eCOA in Clinical Trials
The benefits of eCOA in clinical trials: Improving Data Collection and Patient Experience are discussed. eCOA platforms provide electronic forms that participants can complete directly using familiar devices such as smartphones, tablets, or computers. This not only...
Social Intelligence Report: Patients & Clinical Trials in the U.S.
Safira’s Center for Social & Digital Excellence recently completed a social intelligence report looking at the trends in social conversations from patients and caregivers regarding their feelings and drivers related to clinical trials. Among the top insights...
Tuberculosis: Patient Sentiment
We recently conducted a comprehensive, multilingual analysis of social media conversations regarding tuberculosis, focusing on insights from Japan, the Philippines, India, and Peru. Initially, we sifted through over 3 million posts from 1 million authors, but after...
Ready to start your project now?